Global Alpha Capital Management

Global Alpha runs a concentrated, bottom-up international equity strategy focused on small- and mid-cap companies primarily in developed markets outside North America. The portfolio typically holds 30 to 50 names, with CIO Jean-Pierre Cheylan leading the research process. The team targets businesses with durable competitive advantages, high barriers to entry, and dominant market positions in niche industries.

Jean-Pierre Cheylan, the firm's co-founder and Chief Investment Officer, leads the investment decision-making process alongside a small research team. Cheylan and CEO Robert Beauregard founded the firm together in 2008 after managing international equity portfolios at major Canadian institutions. The flat organizational structure is designed to keep research integrity central to every allocation decision.

No. Global Alpha deliberately excludes Canadian equities from its mandate and maintains minimal exposure to US-listed companies. The firm focuses on developed international markets — primarily Western Europe and Asia-Pacific — where it believes information asymmetry is greatest among small- and mid-cap companies. This geographic discipline is a core part of the firm's identity and value proposition to Canadian institutional clients who already have domestic exposure through other managers.

Global Alpha is an employee-owned firm, with founders Robert Beauregard and Jean-Pierre Cheylan holding significant equity stakes. This independence from bank-owned platforms or public-company structures allows the investment team to maintain a long-term horizon without pressure to gather assets or launch short-term products. The ownership alignment with clients is a key part of the firm's pitch to institutional allocators.

The firm gravitates toward industrial technology, specialty manufacturing, healthcare services, laboratory and automation equipment, and niche financial services. Portfolio holdings have historically included companies like Japan's MISUMI Group in factory-automation components and Switzerland's Tecan Group in laboratory automation. The team avoids sectors where competitive advantages are difficult to sustain or where regulatory risk clouds long-term compounding.